L. R. Edfors

A systematic review and meta-analysis of beta-blockers and renin-angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer.

J. Bland, L. Køber, F. Braunschweig, 2021, European heart journal.